RxDoctor Payments Data

Dalson Seibert, MD

Family Medicine · North Canton, OHNPI 1063625358

Payments from drug & device makers

$5,825in general payments, 2019–2025

Across 378 payments — averaging $15.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$952
  • Novo Nordisk$737
  • AstraZeneca$497
  • Pfizer$429
  • Lilly USA, LLC$367
  • Merck$247
  • plus $3K from 36 others

What the payments were for

  • Food & beverage$5,825100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,825 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$65,397
Medicare patients
203
Services billed
1,908

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban148$139,209
OzempicSemaglutide56$73,936
JardianceEmpagliflozin75$57,509
XareltoRivaroxaban55$54,647
TrulicityDulaglutide34$39,602
ArexvyRsvpref3 Antigen/As01e/Pf100$30,489
MounjaroTirzepatide23$26,079
FarxigaDapagliflozin Propanediol23$21,864
Bydureon BciseExenatide Microspheres14$17,518
LinzessLinaclotide23$14,035
EntrestoSacubitril/Valsartan12$13,204
ShingrixVaricella-Zoster Ge/As01b/Pf57$12,595
SymbicortBudesonide/Formoterol Fumarate22$6,847
Atorvastatin Calcium563$5,896
TradjentaLinagliptin11$5,362

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$429$139,209148 claims
Novo NordiskOzempic$737$73,93656 claims
Lilly USA, LLCTrulicity, Mounjaro$367$65,68057 claims
Boehringer IngelheimJardiance, Tradjenta$71$62,87186 claims
Johnson & JohnsonXarelto$70$54,64755 claims
GSKArexvy, Shingrix$76$43,083157 claims
AstraZenecaFarxiga, Symbicort$497$28,71245 claims
AbbVieLinzess, Synthroid$952$15,67863 claims
NovartisEntresto$94$13,20412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in North Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →